Form D · Pharmaceuticals
Network Life Sciences Inc.
Vancouver, A1 · CIK 0001677233
Offering snapshot reported Jun 17, 2016 · SEC filing
- Reported sold
- $310K Offering amount: $310K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Jun 3, 2016 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 17, 2016 | Amendment | $309,867 | $0vs Jun 16, 2016 | 3 | SEC filing |
| Jun 16, 2016 | Initial | $309,867 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-265218
rate was in CND funds= $400,000 CND
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Bill Thomas | None |
Source: Form D, filed Jun 17, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bill Thomas | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:Vancouver, A1, V2Z2E6